Details for New Drug Application (NDA): 202054
✉ Email this page to a colleague
The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
Summary for 202054
Tradename: | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE |
Applicant: | Indoco |
Ingredient: | dorzolamide hydrochloride; timolol maleate |
Patents: | 0 |
Pharmacology for NDA: 202054
Mechanism of Action | Adrenergic beta-Antagonists Carbonic Anhydrase Inhibitors |
Suppliers and Packaging for NDA: 202054
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 202054 | ANDA | Indoco Remedies Limited | 14445-405 | 14445-405-10 | 1 BOTTLE, DISPENSING in 1 CARTON (14445-405-10) / 10 mL in 1 BOTTLE, DISPENSING |
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 202054 | ANDA | Biocon Pharma Inc. | 70377-082 | 70377-082-11 | 1 BOTTLE, DISPENSING in 1 CARTON (70377-082-11) / 10 mL in 1 BOTTLE, DISPENSING |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 2% BASE;EQ 0.5% BASE | ||||
Approval Date: | Sep 3, 2014 | TE: | AT1 | RLD: | No |
Complete Access Available with Subscription